Compendia Bioscience is a biotechnology startup founded in 2006. The company's slogan, "Harnessing global cancer genomic data to enhance diagnostics and treatments for better patient outcomes," encapsulates its mission of utilizing diverse cancer genomic data to improve patient care. Compendia Bioscience is dedicated to leveraging this global collection of cancer genomic data to drive the discovery, development, and enhancement of cancer diagnostics and treatments.
The company's last investment was a Seed Round investment on 19 November 2007, with the investment coming from Ann Arbor Spark. This investment represents a key milestone in Compendia Bioscience's journey, providing crucial support for its innovative approach to utilizing cancer genomic data. As the company continues to advance its mission, this early investment serves as a testament to the potential impact of its work in the biotechnology industry.
